- Clinical characteristics and outcomes of thrombotic microangiopathy in Malaysia
-
Yap YY, Sathar J, Law KB, Zulkurnain PAB, Edmund SC, Chang KM, Baker R
- KMID: 2451031
- Blood Res.
- 2018 Jun;53(2):130-137.
- doi: 10.5045/br.2018.53.2.130
BACKGROUND: Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13) outcome is unknown hence the survival analysis correlating with ADAMTS-13 activity is conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
-
Keong Liam CC, Tiao JYH, Yap YY, Lee YL, Sathar J, McRae S, Davis A, Curnow J, Bird R, Choi P, Angchaisuksiri P, Tien SL, Mei Lam JC, Oh D, Kim JS, Yoon SS, Wong RSM, Lauren C, Merriman EG, Enjeti A, Smith M, Baker RI
- KMID: 2541063
- Blood Res.
- 2023 Mar;58(1):36-41.
- doi: 10.5045/br.2023.2022133
Background The PLASMIC score is a convenient tool for predicting ADAMTS13 activity of ＜10%. Lactate dehydrogenase (LDH) is widely used as a marker of haemolysis in thrombotic thrombocytopenic purpura (TTP) monitoring, and... -
- CITED
-
- Close
- SHARE
-
- Close
